NCT06112470

Brief Summary

This study focuses on the experience of the military patient reporting a suspected drug allergy, with its own specificities. Suspicions of drug allergies during a mission expose the doctor to difficulties. This study will improve understanding of the allergy patient's point of view. The end result could be a set of ideas for measures to raise awareness among these patients, and motivate them to undergo an allergological assessment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

November 1, 2023

Status Verified

October 1, 2023

Enrollment Period

11 months

First QC Date

October 26, 2023

Last Update Submit

October 31, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patients' experiences of drug allergies

    describe patients' experiences, perceptions, beliefs and knowledge of drug allergies in general practice in the army

    Through study completion (12 months)

Secondary Outcomes (1)

  • Patients' obstacles

    Through study completion (12 months)

Study Arms (1)

Interview

Monocentric qualitative study with a descriptive socio-demographic section, a descriptive qualitative section on the experience and perception of allergy, then on the obstacles to allergological assessment, and finally a descriptive quantitative section to evaluate knowledge of antibiotic therapy.

Other: Interview

Interventions

Semi-structured interview on experiences, perceptions, beliefs and knowledge of drug allergy and barriers to allergological testing, with a view to content analysis.

Interview

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Military personnel reporting a drug allergy to antibiotics

You may qualify if:

  • Military personnel (active or reservist)
  • Reporting a drug allergy during a periodic medical check-up or during a consultation in a medical unit
  • Not opposed to participating in the study.

You may not qualify if:

  • Candidate on admission visit
  • Opposition to study
  • Minor (under 18 years of age)
  • Pregnant, parturient or breast-feeding woman
  • Person deprived of liberty by a judicial or administrative decision, person under psychiatric care
  • Non-French nationals
  • Person of full age subject to a legal protection measure
  • Person unable to express non-opposition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

15ème antenne médicale - Camp des Matelots

Versailles, 78013, France

RECRUITING

MeSH Terms

Interventions

Interviews as Topic

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2023

First Posted

November 1, 2023

Study Start

February 28, 2023

Primary Completion

February 1, 2024

Study Completion

March 1, 2024

Last Updated

November 1, 2023

Record last verified: 2023-10

Locations